N@N

Market Maker Surveillance Report. AUXO, BCRX, FBN, FOLD, HSOL, QRM, Winning Stocks With Lowest Price Friction For Thursday, Ja

January 12, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3743 companies with "abnormal" market making, 3483 companies with positive Friction Factors and 2337 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. AUXILIO INC (OTCBB:AUXO), BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX), FURNITURE BRANDS INTL INC (NYSE:FBN), AMICUS THERAPEUTICS INC (NASDAQ:FOLD), HANWHA SOLARONE CO -SPON ADR (NASDAQ:HSOL), Quest Rare Minerals Limited (NYSE:QRM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     AUXO       $0.200       20.00%       32,910          40.03%       30,078          36.59%       2,832           142     
     BCRX       $0.460       18.33%       535,884         57.49%       395,502         42.43%       140,382         3,052   
     FBN        $0.430       38.05%       1,046,802       45.93%       793,602         34.82%       253,200         5,888   
     FOLD       $0.690       19.69%       116,338         66.60%       58,335          33.40%       58,003          841     
     HSOL       $0.310       18.13%       2,271,922       56.03%       1,782,834       43.97%       489,088         15,777  
     QRM        $0.690       27.06%       477,403         33.21%       436,543         30.37%       40,860          592     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows AUXO with a dollar gain Thursday of $0.20000 and a Friction Factor of 142 shares. That means that it only took 142 more shares of buying than selling to move AUXO higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

AUXILIO INC (OTCBB:AUXO) - Auxilio, Inc. provides managed print services for the health care industry, working exclusively with hospitals and hospital systems in the United States. The company is vendor independent and provides intelligent solutions, a risk free program, and guaranteed savings. Auxilio, Inc. assumes various costs related to print business environments through customized, streamlined, and seamless integration of services at fixed rates. In collaboration, the company works in partnership to assist its hospital-partners in the delivery of patient care. Its services include vendor monitoring, management, and contract negotiation; change management and end-user training programs; utilization management; financial reporting; workflow efficiency management; information systems integration, connectivity, and image migration strategies; and strategy execution working with the customer to execute a long-term image management strategy. Auxilio, Inc. helps hospitals and health systems reduce expenses and create manageable document image management programs by managing their back-office processes. The company sells, integrates, and services automated office equipment, including digital and color copiers, printers, facsimile machines, scanners, and multi-function equipment. Its customers also include integrated health delivery networks. The company is headquartered in Mission Viejo, California.

BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) - BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The company has progressed two compounds into late-stage pivotal clinical trials comprising Peramivir, an anti-viral for influenza; and Forodesine, a purine nucleoside phosphorylase (PNP) inhibitor forcutaneous T-cell lymphoma (CTCL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority (BARDA) within the United States Department of Health and Human Services (HHS). Forodesine has been granted Orphan Drug status by the FDA for three indications, including T-cell non-Hodgkin's lymphoma, including CTCL; CLL and related leukemias, such as T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for the treatment of B-ALL. BioCryst Pharmaceuticals is also testing BCX-4208, a second generation PNP inhibitor, which is in a Phase II study for the treatment of gout. The company utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. It has strategic alliances with the U.S. Department of Health and Human Services; Shionogi & Co., Ltd.; Green Cross Corporation; and Mundipharma International Holdings Limited. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is based in Durham, North Carolina.

FURNITURE BRANDS INTL INC (NYSE:FBN) - Furniture Brands International, Inc. designs, manufactures, sources, and retails home furnishings. It offers case goods, including bedroom, dining room, and living room furniture products; stationary upholstery products comprising sofas, loveseats, sectionals, and chairs; motion upholstered furniture products consisting of recliners and sleep sofas; occasional furniture products, such as accent pieces, home entertainment centers, and home office furniture products, as well as wood, metal, and glass tables; and decorative accessories. The company markets its products under the Broyhill, Lane, Thomasville, Drexel Heritage, Henredon, Hickory Chair, Pearson, Laneventure, and Maitland-Smith brand names. Furniture Brands International sells its products through a network of independently owned furniture retailers, national and regional department stores and chains, and trade showrooms, as well as through various retail channels, including mass merchant stores, single-branded stores, independent dealers, and specialized interior designers. As of December 31, 2009, it operated 37 stores. The company was founded in 1836 and is headquartered in St. Louis, Missouri.

AMICUS THERAPEUTICS INC (NASDAQ:FOLD) - Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, increase the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its lead product candidate includes Amigal, which is in Phase III development for the treatment of Fabry disease. The company also develops AT2220, which is in Phase I testing for the treatment of Pompe disease. In addition, it develops Plicera for the treatment of Gaucher disease. The company was founded in 2002 and is based in Cranbury, New Jersey.

HANWHA SOLARONE CO -SPON ADR (NASDAQ:HSOL) - Hanwha SolarOne, Ltd. provides various energy solutions including silicon ingots, wafers, monocrystalline and polycrystalline solar cells, and solar modules. The company also provides project development and financing services. Its products are used in utility, commercial and government, and residential solar applications on-grid and off-grid. The company was formerly known as Solarfun Power Holdings Co., Ltd. and changed its name to Hanwha SolarOne, Ltd. in December, 2010. The company was founded in 2004 and is based in Qidong, China.

Quest Rare Minerals Limited (NYSE:QRM) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net